Clinical outcomes of patients with COVID-19 and inflammatory rheumatic diseases receiving biological/targeted therapy
BACKGROUND: Anti-cytokine treatments are used in the treatment of severe COVID-19. Other studies have shown statistical significance with TNF inhibitors but not with other biological/targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARD). OBJECTIVES: Compare the rate of severe acute r...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
King Faisal Specialist Hospital and Research Centre
2022-05-01
|
Series: | Annals of Saudi Medicine |
Online Access: | http://www.annsaudimed.net/doi/10.5144/0256-4947.2022.155 |